Abstract
A 45-year-old man suffering from intermittent rectal bleeding was diagnosed with ulcerative colitis involving the descending colon and rectum. After 2 years on ulcerative colitis treatment, he presented with metastatic gastrointestinal tumor, liver and peritoneal spread, and a pelvic mass. Interestingly, he was found to have significant hypercalcemia. He was treated with Imatinib with significant symptomatic and clinical response.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Colitis, Ulcerative / complications*
-
Colitis, Ulcerative / pathology
-
Gastrointestinal Stromal Tumors / complications*
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / pathology
-
Humans
-
Hypercalcemia / complications*
-
Hypercalcemia / diagnosis
-
Imatinib Mesylate
-
Liver Neoplasms / secondary*
-
Male
-
Middle Aged
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / secondary
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Rectum / physiopathology
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate